Finance

Lists
Why is CLBIO up 2,92%?
Dive Deeper
CLBIO:STO
Corline Biomedical AB
14,10 SEK
+2,92%
(+0,40) 1D
13 қаз., 17:29:41 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for CLBIO...
Open
14,10 SEK
High
14,10 SEK
Low
13,30 SEK
Mkt. cap
368,48 млн
Avg. vol.
9,14 мың
Volume
12,54 мың
52-wk high
22,30 SEK
52-wk low
13,15 SEK
EPS
-0,49 SEK
Shares outstanding
26,13 млн
No. of employees
14
Open
14,10 SEK
High
14,10 SEK
Low
13,30 SEK
Mkt. cap
368,48 млн
Avg. vol.
9,14 мың
Volume
12,54 мың
52-wk high
22,30 SEK
52-wk low
13,15 SEK
EPS
-0,49 SEK
Shares outstanding
26,13 млн
No. of employees
14
News stories
From web sources and news partners
About Corline Biomedical AB
CEOHenrik Nittmar
Employees14
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitecorline.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,30 млн
2,10 млн
4,29 млн
4,69 млн
Cost of goods sold
631,00 м.
716,00 м.
-79,00 мың
139,00 м.
Cost of revenue
631,00 м.
716,00 м.
-79,00 мың
139,00 м.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,07 млн
6,47 млн
6,79 млн
6,00 млн
Operating expense
4,04 млн
6,46 млн
6,87 млн
6,02 млн
Total operating expenses
4,67 млн
7,17 млн
6,80 млн
6,16 млн
Operating income
-3,37 млн
-5,07 млн
-2,50 млн
-1,48 млн
Other non operating income
9,00 мың
-30,00 мың
2,00 мың
45,00 мың
EBT including unusual items
-3,36 млн
-5,03 млн
-2,50 млн
-1,44 млн
EBT excluding unusual items
-3,36 млн
-5,03 млн
-2,50 млн
-1,44 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-44,00 мың
-30,00 мың
61,00 мың
-15,00 мың
Net income
-3,36 млн
-5,03 млн
-2,50 млн
-1,44 млн
Net profit margin
-257,39%
-238,93%
-58,28%
-30,62%
Earnings per share
-
-
-
-
Interest and investment income
1,00 мың
38,00 мың
1,00 мың
-
Interest expense
-1,00 мың
-
-
-4,00 мың
Net interest expenses
-
38,00 мың
1,00 мың
-4,00 мың
Depreciation and amortization charges
12,00 мың
20,00 мың
20,00 мың
36,00 мың
EBITDA
-3,36 млн
-5,03 млн
-2,48 млн
-1,44 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары